Innova Captab Share Price
Sector:
864.00 +10.40 (1.22%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
851.85
Today’s High
870.90
52 Week Low
486.60
52 Week High
1259.00
860.05 +6.25 (0.73%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
851.80
Today’s High
867.05
52 Week Low
486.80
52 Week High
1260.00
Key Metrics
- Market Cap (In Cr) 4941.66
- Beta -
- Div. Yield (%) 0
- P/B 5.09
- TTM P/E 39.22
- Peg Ratio 2.01
- Sector P/E 0
- D/E 0
- Open Price 870.9
- Prev Close 853.6
Innova Captab Analysis
Price Analysis
-
1 Week2.14%
-
3 Months-3.26%
-
6 Month-19.16%
-
YTD-23.45%
-
1 Year69.46%
Risk Meter
- 48% Low risk
- 48% Moderate risk
- 48% Balanced Risk
- 48% High risk
- 48% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 1
- 1
- 1
- 1
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 2
- 2
- 2
- 2
Innova Captab News
Breakout stocks to buy or sell: Sumeet Bagadia recommends 5 shares to buy today
2 min read . 24 Jan 2025Innova Captab extends losing streak for the sixth consecutive session, down 18%
3 min read . 15 Jan 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
2 min read . 27 Dec 2024The US wants to cut its reliance on Chinese pharma. These stocks could benefit.
7 min read . 07 Oct 2024Innova Captab Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 1243.68
- Selling/ General/ Admin Expenses Total
- 116.78
- Depreciation/ Amortization
- 24.78
- Other Operating Expenses Total
- 126.65
- Total Operating Expense
- 1082.3
- Operating Income
- 161.38
- Net Income Before Taxes
- 171.02
- Net Income
- 128.26
- Diluted Normalized EPS
- 22.41
- Period
- 2025
- Total Assets
- 1580.41
- Total Liabilities
- 620.99
- Total Equity
- 959.42
- Tangible Book Valueper Share Common Eq
- 164.61
- Period
- 2025
- Cashfrom Operating Activities
- 63.84
- Cashfrom Investing Activities
- -151.59
- Cashfrom Financing Activities
- 91.53
- Net Changein Cash
- 3.79
- Period
- 2024
- Total Revenue
- 1081.3
- Selling/ General/ Admin Expenses Total
- 166.88
- Depreciation/ Amortization
- 15.96
- Other Operating Expenses Total
- 10.58
- Total Operating Expense
- 949.41
- Operating Income
- 131.89
- Net Income Before Taxes
- 129.53
- Net Income
- 94.35
- Diluted Normalized EPS
- 18.65
- Period
- 2024
- Total Assets
- 1320.88
- Total Liabilities
- 489.99
- Total Equity
- 830.89
- Tangible Book Valueper Share Common Eq
- 142.12
- Period
- 2024
- Cashfrom Operating Activities
- 146.34
- Cashfrom Investing Activities
- -498.97
- Cashfrom Financing Activities
- 360.83
- Net Changein Cash
- 8.2
- Period
- 2023
- Total Revenue
- 926.38
- Selling/ General/ Admin Expenses Total
- 105.3
- Depreciation/ Amortization
- 11.08
- Other Operating Expenses Total
- 8.78
- Total Operating Expense
- 830.53
- Operating Income
- 95.85
- Net Income Before Taxes
- 91.8
- Net Income
- 67.95
- Diluted Normalized EPS
- 14.11
- Period
- 2023
- Total Assets
- 704.41
- Total Liabilities
- 427.91
- Total Equity
- 276.51
- Tangible Book Valueper Share Common Eq
- 53.97
- Period
- 2023
- Cashfrom Operating Activities
- 67.12
- Cashfrom Investing Activities
- -90.84
- Cashfrom Financing Activities
- 27.09
- Net Changein Cash
- 3.37
- Period
- 2022
- Total Revenue
- 800.53
- Selling/ General/ Admin Expenses Total
- 40.46
- Depreciation/ Amortization
- 7.5
- Other Operating Expenses Total
- 46.13
- Total Operating Expense
- 712
- Operating Income
- 88.52
- Net Income Before Taxes
- 85.72
- Net Income
- 63.95
- Diluted Normalized EPS
- 13.32
- Period
- 2022
- Total Assets
- 575.48
- Total Liabilities
- 366.87
- Total Equity
- 208.61
- Tangible Book Valueper Share Common Eq
- 39.89
- Period
- 2022
- Cashfrom Operating Activities
- 59.13
- Cashfrom Investing Activities
- -188.35
- Cashfrom Financing Activities
- 124.57
- Net Changein Cash
- -4.64
- Period
- 2021
- Total Revenue
- 410.66
- Selling/ General/ Admin Expenses Total
- 37.91
- Depreciation/ Amortization
- 5.59
- Other Operating Expenses Total
- 0.39
- Total Operating Expense
- 361.76
- Operating Income
- 48.9
- Net Income Before Taxes
- 46.34
- Net Income
- 34.5
- Diluted Normalized EPS
- 7.16
- Period
- 2021
- Total Assets
- 369.62
- Total Liabilities
- 224.8
- Total Equity
- 144.82
- Tangible Book Valueper Share Common Eq
- 30.08
- Period
- 2021
- Cashfrom Operating Activities
- 41.57
- Cashfrom Investing Activities
- -19.67
- Cashfrom Financing Activities
- -19.34
- Net Changein Cash
- 2.56
- Period
- 2020
- Total Revenue
- 373.32
- Selling/ General/ Admin Expenses Total
- 31.35
- Depreciation/ Amortization
- 10.08
- Other Operating Expenses Total
- 0.53
- Total Operating Expense
- 332.46
- Operating Income
- 40.86
- Net Income Before Taxes
- 37.53
- Net Income
- 27.89
- Diluted Normalized EPS
- 5.81
- Period
- 2020
- Total Assets
- 245.06
- Total Liabilities
- 134.71
- Total Equity
- 110.35
- Tangible Book Valueper Share Common Eq
- 22.91
- Period
- 2020
- Cashfrom Operating Activities
- 30.8
- Cashfrom Investing Activities
- -6.04
- Cashfrom Financing Activities
- -23.28
- Net Changein Cash
- 1.48
- Period
- 2019
- Total Revenue
- 355.81
- Selling/ General/ Admin Expenses Total
- 26.72
- Depreciation/ Amortization
- 10.67
- Other Operating Expenses Total
- 1.02
- Total Operating Expense
- 325.64
- Operating Income
- 30.17
- Net Income Before Taxes
- 24.76
- Net Income
- 19.88
- Diluted Normalized EPS
- 4.14
- Period
- 2019
- Total Assets
- 222.95
- Total Liabilities
- 140.47
- Total Equity
- 82.49
- Tangible Book Valueper Share Common Eq
- 17.06
- Period
- 2019
- Cashfrom Operating Activities
- 18.87
- Cashfrom Investing Activities
- -9.13
- Cashfrom Financing Activities
- -9.2
- Net Changein Cash
- 0.54
- Period
- 2025-03-31
- Total Revenue
- 314.74
- Selling/ General/ Admin Expenses Total
- 35.52
- Depreciation/ Amortization
- 9.8
- Other Operating Expenses Total
- 33.52
- Total Operating Expense
- 276.86
- Operating Income
- 37.88
- Net Income Before Taxes
- 39.31
- Net Income
- 29.57
- Diluted Normalized EPS
- 5.17
- Period
- 2025-03-31
- Total Assets
- 1580.41
- Total Liabilities
- 620.99
- Total Equity
- 959.42
- Tangible Book Valueper Share Common Eq
- 164.61
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 63.84
- Cashfrom Investing Activities
- -151.59
- Cashfrom Financing Activities
- 91.53
- Net Changein Cash
- 3.79
- Period
- 2024-12-31
- Total Revenue
- 316.46
- Selling/ General/ Admin Expenses Total
- 28.21
- Depreciation/ Amortization
- 5.13
- Other Operating Expenses Total
- 31.76
- Total Operating Expense
- 275.03
- Operating Income
- 41.43
- Net Income Before Taxes
- 45.59
- Net Income
- 34.2
- Diluted Normalized EPS
- 5.97
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 318.2
- Selling/ General/ Admin Expenses Total
- 28.17
- Depreciation/ Amortization
- 4.99
- Other Operating Expenses Total
- 33.31
- Total Operating Expense
- 273.46
- Operating Income
- 44.74
- Net Income Before Taxes
- 46.81
- Net Income
- 35
- Diluted Normalized EPS
- 6.12
- Period
- 2024-09-30
- Total Assets
- 1434.55
- Total Liabilities
- 539.25
- Total Equity
- 895.3
- Tangible Book Valueper Share Common Eq
- 153.4
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 31.61
- Cashfrom Investing Activities
- -55.92
- Cashfrom Financing Activities
- 15.96
- Net Changein Cash
- -8.35
- Period
- 2024-06-30
- Total Revenue
- 294.27
- Selling/ General/ Admin Expenses Total
- 24.88
- Depreciation/ Amortization
- 4.85
- Other Operating Expenses Total
- 28.05
- Total Operating Expense
- 256.95
- Operating Income
- 37.32
- Net Income Before Taxes
- 39.31
- Net Income
- 29.48
- Diluted Normalized EPS
- 5.15
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 262.63
- Selling/ General/ Admin Expenses Total
- 25.9
- Depreciation/ Amortization
- 3.41
- Other Operating Expenses Total
- 30.39
- Total Operating Expense
- 227.96
- Operating Income
- 34.67
- Net Income Before Taxes
- 39.55
- Net Income
- 28.72
- Diluted Normalized EPS
- 9.38
- Period
- 2024-03-31
- Total Assets
- 1320.88
- Total Liabilities
- 489.99
- Total Equity
- 830.89
- Tangible Book Valueper Share Common Eq
- 142.12
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 146.34
- Cashfrom Investing Activities
- -498.97
- Cashfrom Financing Activities
- 360.83
- Net Changein Cash
- 8.2
- Period
- 2023-12-31
- Total Revenue
- 302.49
- Selling/ General/ Admin Expenses Total
- 25.63
- Depreciation/ Amortization
- 4.93
- Other Operating Expenses Total
- 30.18
- Total Operating Expense
- 262.82
- Operating Income
- 39.67
- Net Income Before Taxes
- 35.2
- Net Income
- 25.13
- Diluted Normalized EPS
- 4.39
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Innova Captab Technical
Moving Average
SMA
- 5 Day848.71
- 10 Day874.21
- 20 Day876.78
- 50 Day888.19
- 100 Day869.4
- 300 Day888.41
Innova Captab Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Bondada Engineering
- 452.25
- -6.25
- -1.36
- 753.98
- 330
- 4975.99
- Yatharth Hospital Tra Ca Ser
- 529.2
- 3.9
- 0.74
- 692.85
- 345.35
- 5101.01
- Innova Captab
- 864
- 10.4
- 1.22
- 1259
- 486.6
- 4941.66
- Entero Healthcare Solutions
- 1131.35
- 15.55
- 1.39
- 1583
- 1030
- 4922.38
- Indus Infra Trust Unt
- 109.2
- -0.66
- -0.6
- 118.51
- 95.21
- 4836.89
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Bondada Engineering
- 45.43
- 11.49
- -
- -
- Yatharth Hospital Tra Ca Ser
- 35.72
- 3.16
- 17.97
- 13.87
- Innova Captab
- 38.66
- 5.17
- 19.49
- 8.72
- Entero Healthcare Solutions
- 51.94
- 2.85
- 1.77
- 0.55
- Indus Infra Trust Unt
- 67.63
- 0.98
- -
- -
Innova Captab Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 19-May-25
- Audited Results
- 05-Feb-25
- Quarterly Results & Others
- 07-Nov-24
- Quarterly Results
- 09-Aug-24
- Quarterly Results
- 29-May-24
- Audited Results
- 13-Feb-24
- Quarterly Results
- 18-Jan-24
- Quarterly Results




